Survival of node-positive (≥3) breast cancers

被引：0

作者：

Gulya, E ^{[1
]}

Juhasz, M ^{[1
]}

Kormos, Z ^{[1
]}

Pajkos, G ^{[1
]}

Stotz, G ^{[1
]}

机构：

[1] Minist Interior, Cent Hosp, Dept Oncol, Budapest, Hungary

来源：

10TH INTERNATIONAL CONGRESS ON SENOLOGY - BREAST DISEASES OF THE SENOLOGIC INTERNATIONAL SOCIETY | 1998年

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Survival of breast cancer patients (BCP) depends on a lot of factors. The most important prognostic factors in breast cancer are: the size of the tumour, number of lymph node metastases, nuclear grade, receptor and menopausal status, age. In addition the resistance of tumour cells for cytostatic treatment, status of immune system, accompanying diseases all affect the course of breast cancer.

引用

页码：747 / 751

页数：5

共 50 条

[31] Chemotherapy for older women with node-positive breast cancer
Ginsburg, D
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2001, 165 (05) : 525 - +
[32] Prognostic Value of Lymph Node Ratio in Node-positive Breast Cancer
Dings, P. J.
Francissen, C. M.
Elferink, M. A.
Strobbe, L. J.
Van Laarhoven, H. W.
De Wilt, J. H.
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S62 - S62
[33] The lymph node ratio as prognostic factor in node-positive breast cancer
Voordeckers, M
Vinh-Hung, V
Van de Steene, J
Lamote, J
Storme, G
RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S243 - S244
[34] Radiotherapy or surgery for the axilla in node-positive breast cancer?
Livi, Lorenzo
Meattini, Icro
LANCET ONCOLOGY, 2015, 16 (02): : E53 - E53
[35] Epirubicin for adjuvant therapy in node-positive breast cancer
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2000, 42 (1071): : 12 - 13
[36] Prognostic variables in node-negative and node-positive breast cancer
Gasparini, G
BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) : 321 - 331
[37] PET plus MARI in Node-Positive Breast Cancer
不详
JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (05) : 16N - 17N
[38] Postoperative PINP in serum reflects metastatic potential and poor survival in node-positive breast cancer
Jukkola, A
Bloigu, R
Holli, K
Joensuu, H
Valavaara, R
Risteli, J
Blanco, G
ANTICANCER RESEARCH, 2001, 21 (4B) : 2873 - 2876
[39] Long-term survival in node-positive breast cancer treated by locoregional therapy alone
H Joensuu
L Pylkkänen
S Toikkanen
British Journal of Cancer, 1998, 78 : 795 - 799
[40] Nomogram Model of LNR Predicts Survival in Premenopausal Patients with Node-positive Luminal Breast Cancer
Qin, Tao
Zeng, Yin-Duo
Lu, Qianyi
Zhang, Xinke
Qin, Ge
Zheng, Qiufan
Xu, Fei
Peng, Roujun
Yuan, Zhongyu
Wang, Shusen
ANTICANCER RESEARCH, 2017, 37 (08) : 4575 - 4586

← 1 2 3 4 5 →